TSPAN8 and malignant colon neoplasm: In another practical application, Kang et al. demonstrated a NIR-SERRS dot-based ratiometric quantification method for validating anti-tetraspanin-8 (TSPAN8) antibodies in human colon cancer in vivo (Fig. 6e)6.